Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Breast Cancer Prognostic Factors in the Digital Era: Comparison of Nottingham Grade using Whole Slide Images and Glass Slides.

Davidson TM, Rendi MH, Frederick PD, Onega T, Allison KH, Mercan E, BrunyƩ TT, Shapiro LG, Weaver DL, Elmore JG.

J Pathol Inform. 2019 Apr 3;10:11. doi: 10.4103/jpi.jpi_29_18. eCollection 2019.

2.

Unexpected PAX8 Immunoreactivity in Metastatic High-grade Breast Cancer.

Kilgore MR, Bosch DE, Adamson KH, Swanson PE, Dintzis SM, Rendi MH.

Appl Immunohistochem Mol Morphol. 2018 Oct 24. doi: 10.1097/PAI.0000000000000707. [Epub ahead of print]

PMID:
30358609
3.

Evaluation of Intraoperative Assessments in the Management of Endometrial Carcinoma: A Retrospective Quality Assurance Review.

Strickland SV, Rendi MH, Garcia RL, Norquist BS, Pennington KP, Kilgore MR.

Int J Gynecol Pathol. 2018 Sep;37(5):414-420. doi: 10.1097/PGP.0000000000000445.

PMID:
30102260
4.

Impact of oophorectomy and hormone suppression in low grade endometrial stromal sarcoma: A multicenter review.

Stewart LE, Beck TL, Giannakopoulos NV, Rendi MH, Isacson C, Goff BA.

Gynecol Oncol. 2018 May;149(2):297-300. doi: 10.1016/j.ygyno.2018.03.008. Epub 2018 Mar 11.

PMID:
29534832
5.

Diffusion-weighted MRI characteristics associated with prognostic pathological factors and recurrence risk in invasive ER+/HER2- breast cancers.

Amornsiripanitch N, Nguyen VT, Rahbar H, Hippe DS, Gadi VK, Rendi MH, Partridge SC.

J Magn Reson Imaging. 2018 Jul;48(1):226-236. doi: 10.1002/jmri.25909. Epub 2017 Nov 27.

6.

Comparison of Proliferation Markers Ki67 and Phosphohistone-H3 (pHH3) in Breast Ductal Carcinoma In Situ.

Bosch DE, Kilgore MR, Schmidt RA, Swanson PE, Rendi MH, Chang OH.

Appl Immunohistochem Mol Morphol. 2017 Sep;25(8):543-547. doi: 10.1097/PAI.0000000000000555.

PMID:
28885232
7.

NDER: A Novel Web Application for Teaching Histology to Medical Students.

Parker EU, Reder NP, Glasser D, Henriksen J, Kilgore MR, Rendi MH.

Acad Pathol. 2017 Feb 10;4:2374289517691061. doi: 10.1177/2374289517691061. eCollection 2017 Jan-Dec.

8.

Epithelioid angiosarcoma arising in a uterine leiomyoma with associated elevated CA-125: A case report.

Strickland SV, Kilgore MR, Simons EJ, Rendi MH.

Gynecol Oncol Rep. 2017 May 5;21:1-4. doi: 10.1016/j.gore.2017.05.001. eCollection 2017 Aug.

9.

Surgical implications and variability in the use of the flat epithelial atypia diagnosis on breast biopsy specimens.

Samples LS, Rendi MH, Frederick PD, Allison KH, Nelson HD, Morgan TR, Weaver DL, Elmore JG.

Breast. 2017 Aug;34:34-43. doi: 10.1016/j.breast.2017.04.004. Epub 2017 May 3.

10.

Absence of functional fetal regulatory T cells in humans causes in utero organ-specific autoimmunity.

Allenspach EJ, Finn LS, Rendi MH, Eken A, Singh AK, Oukka M, Taylor SD, Altman MC, Fligner CL, Ochs HD, Rawlings DJ, Torgerson TR.

J Allergy Clin Immunol. 2017 Aug;140(2):616-619.e7. doi: 10.1016/j.jaci.2017.02.017. Epub 2017 Mar 16. No abstract available.

PMID:
28322850
11.

Apparent diffusion coefficient values may help predict which MRI-detected high-risk breast lesions will upgrade at surgical excision.

Cheeney S, Rahbar H, Dontchos BN, Javid SH, Rendi MH, Partridge SC.

J Magn Reson Imaging. 2017 Oct;46(4):1028-1036. doi: 10.1002/jmri.25656. Epub 2017 Feb 9.

PMID:
28181343
12.

Reflex test reminders in required cancer synoptic templates decrease order entry error: An analysis of mismatch repair immunohistochemical orders to screen for Lynch syndrome.

Kilgore MR, McIlwain CA, Schmidt RA, Norquist BM, Swisher EM, Garcia RL, Rendi MH.

J Pathol Inform. 2016 Nov 29;7:48. eCollection 2016.

13.

'Non-classical' HER2 FISH results in breast cancer: a multi-institutional study.

Ballard M, Jalikis F, Krings G, Schmidt RA, Chen YY, Rendi MH, Dintzis SM, Jensen KC, West RB, Sibley RK, Troxell ML, Allison KH.

Mod Pathol. 2017 Feb;30(2):227-235. doi: 10.1038/modpathol.2016.175. Epub 2016 Oct 14.

14.

NDER: A novel web application using annotated whole slide images for rapid improvements in human pattern recognition.

Reder NP, Glasser D, Dintzis SM, Rendi MH, Garcia RL, Henriksen JC, Kilgore MR.

J Pathol Inform. 2016 Jul 26;7:31. doi: 10.4103/2153-3539.186913. eCollection 2016.

15.

Histological features associated with diagnostic agreement in atypical ductal hyperplasia of the breast: illustrative cases from the B-Path study.

Allison KH, Rendi MH, Peacock S, Morgan T, Elmore JG, Weaver DL.

Histopathology. 2016 Dec;69(6):1028-1046. doi: 10.1111/his.13035. Epub 2016 Sep 23.

16.

Diffusion-weighted imaging reflects variable cellularity and stromal density present in breast fibroadenomas.

Parsian S, Giannakopoulos NV, Rahbar H, Rendi MH, Chai X, Partridge SC.

Clin Imaging. 2016 Sep-Oct;40(5):1047-54. doi: 10.1016/j.clinimag.2016.06.002. Epub 2016 Jun 13.

17.

Region of interest identification and diagnostic agreement in breast pathology.

Nagarkar DB, Mercan E, Weaver DL, BrunyƩ TT, Carney PA, Rendi MH, Beck AH, Frederick PD, Shapiro LG, Elmore JG.

Mod Pathol. 2016 Sep;29(9):1004-11. doi: 10.1038/modpathol.2016.85. Epub 2016 May 20.

18.

Screening MRI in Women With a Personal History of Breast Cancer.

Lehman CD, Lee JM, DeMartini WB, Hippe DS, Rendi MH, Kalish G, Porter P, Gralow J, Partridge SC.

J Natl Cancer Inst. 2016 Jan 7;108(3). pii: djv349. doi: 10.1093/jnci/djv349. Print 2016 Mar.

PMID:
26744477
19.

Using IHC to Predict Local Recurrence/Progression of DCIS: A Search for a More Cost-effective Solution.

Kilgore MR, Chang OH, Swanson PE, Schmidt RA, Garcia RL, Rendi MH.

Breast J. 2016 Mar-Apr;22(2):247-8. doi: 10.1111/tbj.12561. Epub 2015 Dec 23. No abstract available.

PMID:
26696338
20.

Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?

Rahbar H, Parsian S, Lam DL, Dontchos BN, Andeen NK, Rendi MH, Lehman CD, Partridge SC.

Clin Imaging. 2016 Jan-Feb;40(1):125-9. doi: 10.1016/j.clinimag.2015.07.026. Epub 2015 Jul 26.

21.

Adjuvant Endocrine Therapy in Patients with Ductal Carcinoma In Situ: A Population-Based Retrospective Analysis from 2005 to 2012 in the National Cancer Data Base.

Flanagan MR, Rendi MH, Gadi VK, Calhoun KE, Gow KW, Javid SH.

Ann Surg Oncol. 2015 Oct;22(10):3264-72. doi: 10.1245/s10434-015-4668-z. Epub 2015 Jul 23.

22.

Pleomorphic Lobular Carcinoma In Situ: Radiologic-Pathologic Features and Clinical Management.

Flanagan MR, Rendi MH, Calhoun KE, Anderson BO, Javid SH.

Ann Surg Oncol. 2015 Dec;22(13):4263-9. doi: 10.1245/s10434-015-4552-x. Epub 2015 Apr 17.

23.

DNA repair mutations and outcomes in ovarian cancer--response.

Swisher EM, Norquist BM, Pennington KP, Rendi MH, Garcia RL.

Clin Cancer Res. 2015 Feb 1;21(3):659. doi: 10.1158/1078-0432.CCR-14-2805. No abstract available.

24.

A framework for evaluating diagnostic discordance in pathology discovered during research studies.

Feng S, Weaver DL, Carney PA, Reisch LM, Geller BM, Goodwin A, Rendi MH, Onega T, Allison KH, Tosteson AN, Nelson HD, Longton G, Pepe M, Elmore JG.

Arch Pathol Lab Med. 2014 Jul;138(7):955-61. doi: 10.5858/arpa.2013-0263-OA.

25.

Beta-human chorionic gonadotropin expression in recurrent and metastatic giant cell tumors of bone: a potential mimicker of germ cell tumor.

Lawless ME, Jour G, Hoch BL, Rendi MH.

Int J Surg Pathol. 2014 Oct;22(7):617-22. doi: 10.1177/1066896914534466. Epub 2014 May 15.

PMID:
24831855
26.

Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas.

Pennington KP, Walsh T, Harrell MI, Lee MK, Pennil CC, Rendi MH, Thornton A, Norquist BM, Casadei S, Nord AS, Agnew KJ, Pritchard CC, Scroggins S, Garcia RL, King MC, Swisher EM.

Clin Cancer Res. 2014 Feb 1;20(3):764-75. doi: 10.1158/1078-0432.CCR-13-2287. Epub 2013 Nov 15.

27.

Painful clitoromegaly caused by rare epithelioid hemangioma.

Gray HJ, Rendi MH, Holmes M.

Gynecol Oncol Case Rep. 2012 Dec 31;4:60-2. doi: 10.1016/j.gynor.2012.12.007. eCollection 2012.

28.

Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy.

Rendi MH, Dintzis SM, Lehman CD, Calhoun KE, Allison KH.

Ann Surg Oncol. 2012 Mar;19(3):914-21. doi: 10.1245/s10434-011-2034-3. Epub 2011 Aug 23.

PMID:
21861212
29.

Gonococcal ascending aortitis with penetrating ulcers and intraluminal thrombus.

Woo JS, Rabkin DG, Mokadam NA, Rendi MH, Aldea GS.

Ann Thorac Surg. 2011 Mar;91(3):910-2. doi: 10.1016/j.athoracsur.2010.08.017.

PMID:
21353028
30.

Benign breast cyst without associated gynecomastia in a male patient: a case report.

Parsian S, Rahbar H, Rendi MH, Lehman CD.

J Radiol Case Rep. 2011;5(11):35-40. doi: 10.3941/jrcr.v5i11.869. Epub 2011 Nov 1.

31.

The selective estrogen receptor modulator arzoxifene and the rexinoid LG100268 cooperate to promote transforming growth factor beta-dependent apoptosis in breast cancer.

Rendi MH, Suh N, Lamph WW, Krajewski S, Reed JC, Heyman RA, Berchuck A, Liby K, Risingsong R, Royce DB, Williams CR, Sporn MB.

Cancer Res. 2004 May 15;64(10):3566-71.

32.

Cutaneous metastasis of rectal adenocarcinoma.

Rendi MH, Dhar AD.

Dermatol Nurs. 2003 Apr;15(2):131-2. Review.

PMID:
12751347
33.

A novel dicyanotriterpenoid, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-onitrile, active at picomolar concentrations for inhibition of nitric oxide production.

Honda T, Honda Y, Favaloro FG Jr, Gribble GW, Suh N, Place AE, Rendi MH, Sporn MB.

Bioorg Med Chem Lett. 2002 Apr 8;12(7):1027-30.

PMID:
11909709
34.

Interaction between Ustilago maydis REC2 and RAD51 genes in DNA repair and mitotic recombination.

Ferguson DO, Rice MC, Rendi MH, Kotani H, Kmiec EB, Holloman WK.

Genetics. 1997 Feb;145(2):243-51.

Supplemental Content

Loading ...
Support Center